![]() | |
Clinical data | |
---|---|
Other names | N-Methyl-1-(3,4-methylenedioxyphenyl)-1-ethanamine; MDM1EA; α,N-Dimethyl-3,4-methylenedioxybenzylamine; α,N-DMMDBA; α,N-Dimethylpiperonylamine; α,N-Dimethyl-1,3-benzodioxole-5-methanamine |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
Chemical and physical data | |
Formula | C10H13NO2 |
Molar mass | 179.219 g·mol−1 |
3D model (JSmol) | |
| |
|
N-Methyl-1-(3,4-methylenedioxyphenyl)-1-ethanamine (MDM1EA), also known as α,N-dimethyl-3,4-methylenedioxybenzylamine (α,N-DMMDBA) or as α,N-dimethylpiperonylamine, is an entactogen-like drug of the benzylamine family related to MDMA.[1][2][3] It is the analogue of MDMA in which the side chain has been shortened by one carbon atom.[1][2][3]
The drug has been found to be a weak serotonin reuptake inhibitor and partially substituted for MDMA in rodent drug discrimination tests at the highest assessed doses.[1][2][4][3] The effects of α,N-DMMDBA in humans are unknown.[1]
It is not a controlled substance in the United States as of 2011.[1]
Homo-MDMA (HMDMA), an analogue of MDMA in which the side chain was extended by one carbon atom, has also been synthesized and studied.[2][3] It partially substituted for MDMA similarly to MDM1EA.[2][3]
See also
[edit]- ALPHA
- M-ALPHA
- Benzylpiperazine (BZP)
- Methylenedioxybenzylpiperazine (MDBZP)
- Homo-MDA
- Homo-MDMA
References
[edit]- ^ a b c d e Shulgin A, Manning T, Daley PF (2011). "#45. α,N-DMMDBA". The Shulgin Index, Volume One: Psychedelic Phenethylamines and Related Compounds. Vol. 1. Berkeley, CA: Transform Press. pp. 80–81. ISBN 978-0-9630096-3-0. OCLC 709667010.
- ^ a b c d e Trachsel D, Lehmann D, Enzensperger C (2013). Phenethylamine: von der Struktur zur Funktion [Phenethylamines: From Structure to Function]. Nachtschatten-Science (in German). Solothurn: Nachtschatten-Verlag. p. 594. ISBN 978-3-03788-700-4. OCLC 858805226. Retrieved 29 January 2025.
- ^ a b c d e Bronson ME, Barrios-Zambrano L, Jiang W, Clark CR, DeRuiter J, Newland MC (December 1994). "Behavioral and developmental effects of two 3,4-methylenedioxymethamphetamine (MDMA) derivatives". Drug and Alcohol Dependence. 36 (3): 161–166. doi:10.1016/0376-8716(94)90141-4. PMID 7889806.
- ^ Hashimoto K, Maeda H, Goromaru T (September 1992). "Antagonism of 3,4-methylenedioxymethamphetamine-induced neurotoxicity in rat brain by 1-piperonylpiperazine". European Journal of Pharmacology. 228 (2–3): 171–174. doi:10.1016/0926-6917(92)90027-a. PMID 1280228.
External links
[edit]DATTooltip Dopamine transporter (DRIsTooltip Dopamine reuptake inhibitors) |
| ||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
NETTooltip Norepinephrine transporter (NRIsTooltip Norepinephrine reuptake inhibitors) |
| ||||||||||||||
SERTTooltip Serotonin transporter (SRIsTooltip Serotonin reuptake inhibitors) |
| ||||||||||||||
VMATsTooltip Vesicular monoamine transporters | |||||||||||||||
Others |
| ||||||||||||||
![]() | This psychoactive drug-related article is a stub. You can help Wikipedia by expanding it. |
- CS1 German-language sources (de)
- Articles with short description
- Short description matches Wikidata
- Articles without EBI source
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without UNII source
- Drugs missing an ATC code
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- All stub articles